Works matching AU Romieu, Gilles


Results: 31
    1
    2
    3
    4

    Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follow-Up Results of the UNICANCER-PACS01 Trial.

    Published in:
    Oncologist, 2012, v. 17, n. 7, p. 900, doi. 10.1634/theoncologist.2011-0442
    By:
    • COUDERT, BRUNO;
    • ASSELAIN, BERNARD;
    • CAMPONE, MARIO;
    • SPIELMANN, MARC;
    • MACHIELS, JEAN-PASCAL;
    • PÉNAULT-LLORCA, FRÉDÉRIQUE;
    • SERIN, DANIEL;
    • LÉVY, CHRISTELLE;
    • ROMIEU, GILLES;
    • CANON, JEAN-LUC;
    • ORFEUVRE, HUBERT;
    • PIOT, GILLES;
    • PETIT, THIERRY;
    • JERUSALEM, GUY;
    • AUDHUY, BRUNO;
    • VEYRET, CORINNE;
    • BEAUDUIN, MARC;
    • EYMARD, JEAN-CHRISTOPHE;
    • MARTIN, ANNE-LAURE;
    • ROCHÉ, HENRI
    Publication type:
    Article
    5

    VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 414, doi. 10.3390/ph13110414
    By:
    • Gal, Jocelyn;
    • Milano, Gérard;
    • Brest, Patrick;
    • Ebran, Nathalie;
    • Gilhodes, Julia;
    • Llorca, Laurence;
    • Dubot, Coraline;
    • Romieu, Gilles;
    • Desmoulins, Isabelle;
    • Brain, Etienne;
    • Goncalves, Anthony;
    • Ferrero, Jean-Marc;
    • Cottu, Paul-Henri;
    • Debled, Marc;
    • Tredan, Olivier;
    • Chamorey, Emmanuel;
    • Merlano, Marco Carlo;
    • Lemonnier, Jérôme;
    • Etienne-Grimaldi, Marie-Christine;
    • Pierga, Jean-Yves
    Publication type:
    Article
    6
    7
    8

    New advances in DPYD genotype and risk of severe toxicity under capecitabine.

    Published in:
    PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0175998
    By:
    • Etienne-Grimaldi, Marie-Christine;
    • Boyer, Jean-Christophe;
    • Beroud, Christophe;
    • Mbatchi, Litaty;
    • van Kuilenburg, André;
    • Bobin-Dubigeon, Christine;
    • Thomas, Fabienne;
    • Chatelut, Etienne;
    • Merlin, Jean-Louis;
    • Pinguet, Frédéric;
    • Ferrand, Christophe;
    • Meijer, Judith;
    • Evrard, Alexandre;
    • Llorca, Laurence;
    • Romieu, Gilles;
    • Follana, Philippe;
    • Bachelot, Thomas;
    • Chaigneau, Loic;
    • Pivot, Xavier;
    • Dieras, Véronique
    Publication type:
    Article
    9
    10
    11
    12

    A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2016, v. 156, n. 2, p. 301, doi. 10.1007/s10549-016-3750-y
    By:
    • Curigliano, Giuseppe;
    • Romieu, Gilles;
    • Campone, Mario;
    • Dorval, Thierry;
    • Duck, Lionel;
    • Canon, Jean-Luc;
    • Roemer-Becuwe, Celia;
    • Roselli, Mario;
    • Neciosup, Silvia;
    • Burny, Wivine;
    • Callegaro, Andrea;
    • Sousa Alves, Pedro;
    • Louahed, Jamila;
    • Brichard, Vincent;
    • Lehmann, Frédéric
    Publication type:
    Article
    13
    14
    15

    A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.

    Published in:
    Breast Cancer Research & Treatment, 2008, v. 110, n. 2, p. 327, doi. 10.1007/s10549-007-9726-1
    By:
    • Stephen Johnston;
    • Vladimir Semiglazov;
    • George Manikhas;
    • Dominique Spaeth;
    • Gilles Romieu;
    • David Dodwell;
    • Andrew Wardley;
    • Patrick Neven;
    • Annick Bessems;
    • Youn Park;
    • Peter De Porre;
    • Juan Perez Ruixo;
    • Angela Howes
    Publication type:
    Article
    16
    17

    Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.

    Published in:
    Nutrients, 2020, v. 12, n. 10, p. 3081, doi. 10.3390/nu12103081
    By:
    • Jacot, William;
    • Arnaud, Antoine;
    • Jarlier, Marta;
    • Lefeuvre-Plesse, Claudia;
    • Dalivoust, Philippe;
    • Senesse, Pierre;
    • Azzedine, Ahmed;
    • Tredan, Olivier;
    • Sadot-Lebouvier, Sophie;
    • Mas, Sébastien;
    • Carayol, Marion;
    • Bleuse, Jean-Pierre;
    • Gourgou, Sophie;
    • Janiszewski, Chloé;
    • Launay, Silene;
    • D'Hondt, Véronique;
    • Lauridant, Géraldine;
    • Grenier, Julien;
    • Romieu, Gilles;
    • Ninot, Gregory
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67431-6
    By:
    • Delrieu, Lidia;
    • Jacquet, Emmanuelle;
    • Segura-Ferlay, Céline;
    • Blanc, Ellen;
    • Febvey-Combes, Olivia;
    • Friedenreich, Christine;
    • Romieu, Gilles;
    • Jacot, William;
    • Rios, Maria;
    • Heudel, Pierre-Etienne;
    • Roemer-Becuwe, Célia;
    • Jouannaud, Christelle;
    • Tredan, Olivier;
    • Chaigneau, Loïc;
    • Arnedos, Monica;
    • Orfeuvre, Hubert;
    • Quenel-Tueux, Nathalie;
    • Jacquin, Jean-Philippe;
    • Ferrero, Jean-Marc;
    • Moullet, Isabelle
    Publication type:
    Article
    24

    PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.

    Published in:
    Breast Cancer Research & Treatment, 2019, v. 177, n. 3, p. 659, doi. 10.1007/s10549-019-05349-y
    By:
    • Jacot, William;
    • Dalenc, Florence;
    • Lopez-Crapez, Evelyne;
    • Chaltiel, Leonor;
    • Durigova, Anna;
    • Gros, Nathalie;
    • Lozano, Nicolas;
    • Lacaze, Jean-Louis;
    • Pouderoux, Stéphane;
    • Gladieff, Laurence;
    • Romieu, Gilles;
    • Roché, Henri;
    • Filleron, Thomas;
    • Lamy, Pierre-Jean
    Publication type:
    Article
    25

    Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.

    Published in:
    NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0005-y
    By:
    • Pivot, Xavier;
    • Romieu, Gilles;
    • Fumoleau, Pierre;
    • Rios, Maria;
    • Bonnefoi, Hervé;
    • Bachelot, Thomas;
    • Soulié, Patrick;
    • Jouannaud, Christelle;
    • Bourgeois, Hugues;
    • Petit, Thierry;
    • Tennevet, Isabelle;
    • Assouline, David;
    • Mathieu, Marie-Christine;
    • Jacquin, Jean-Philippe;
    • Lavau-Denes, Sandrine;
    • Darut-Jouve, Ariane;
    • Ferrero, Jean-Marc;
    • Tarpin, Carole;
    • Lévy, Christelle;
    • Delecroix, Valérie
    Publication type:
    Article
    27
    28
    29
    30
    31